在现实世界临床实践中治疗胸腺癌的关键治疗剂
Akiko Tateishi1, Yusuke Okuma2, Yasushi Goto1
1Thoracic Oncology Department, National Cancer Center Hospital, Tokyo, Japan.
Anticancer research
|December 3, 2024
概括
卡博普拉丁+帕克利塔塞尔 (CP) 和伦瓦提尼布在转移性胸腺癌中显示出有效性. 仔细考虑治疗策略至关重要,特别是对于肝转移的患者,因为其他药物如S-1和sunitinib具有可变的反应.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
- 癌症治疗方法 癌症治疗方法
背景情况:
- 胸膜癌是一种罕见的恶性瘤,在无法切除的病例中预后不佳.
- 卡博普拉丁+帕克利塔塞尔 (CP),伦瓦提尼布,S-1和苏尼提尼布在胸腺癌中的疗效尚未得到充分证实.
- 一些患者在使用这些药物治疗后经历了肝转移的增加.
研究的目的:
- 评估卡博普拉丁+帕克利塔塞尔 (CP),伦瓦提尼布,S-1和苏尼提尼布在转移性胸膜癌患者的临床结果.
- 评估治疗疗效,包括无进展生存率 (PFS),客观反应率 (ORR) 和肝转移反应率 (LMRR).
- 为了确定治疗反应的潜在差异,特别是在肝转移控制方面.
主要方法:
- 在2006年至2023年期间治疗的178名转移性胸腺癌患者的回顾性分析.
- 临床结果的评估:PFS,ORR,疾病控制率 (DCR),LMR和肝转移控制率 (LMCR).
- 治疗CP,lenvatinib,S-1和sunitinib作为一线,二线和三线疗法的疗效比较.
主要成果:
- 卡博普拉丁+帕克利塔塞尔 (CP) 显示PFS中位数为6.8个月,客观响应率 (ORR) 为41.6%.
- 伦瓦提尼布显示最长的PFS中位数为9.4个月,而CP的肝转移反应率 (LMRR) 为40.9%.
- 关于"逆反应" (肝转移的增加) 观察到伦瓦提尼布 (20%),S-1 (3.4%) 和苏尼提尼布 (8.3%).
结论:
- 卡博普拉丁+帕克利塔塞尔 (CP) 和伦瓦替尼是转移性胸膜癌的有效治疗方法.
- S-1和sunitinib表现出临床活性,但肝转移反应具有变化.
- 量身定制的治疗策略是必不可少的,特别是对于肝脏参与胸腺癌的患者.
更多相关视频
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
460
相关概念视频
Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
